{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:31:04Z","timestamp":1762507864141,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11239-019-01944-4","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:13:34Z","timestamp":1567790014000},"page":"220-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-330X","authenticated-orcid":false,"given":"Ming Sheng","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dee","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Chunilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"1944_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1378\/chest.129.1.192","volume":"129","author":"M Nijkeuter","year":"2006","unstructured":"Nijkeuter M, Hovens MMC, Davidson BL, Huisman MV (2006) Resolution of thromboemboli in patients with acute pulmonary embolism. Chest. 129:192\u2013197. \nhttps:\/\/doi.org\/10.1378\/chest.129.1.192","journal-title":"Chest"},{"key":"1944_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/jth.12150","volume":"11","author":"J van Es","year":"2013","unstructured":"van Es J, Douma RA, Kamphuisen PW, Gerdes VEA, Verhamme P, Wells PS, Bounameaux H, Lensing AWA, B\u00fcller HR (2013) Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy. J Thromb Haemost 11:679\u2013685. \nhttps:\/\/doi.org\/10.1111\/jth.12150","journal-title":"J Thromb Haemost"},{"key":"1944_CR3","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1111\/j.1538-7836.2011.04533.x","volume":"9","author":"A Hamadah","year":"2011","unstructured":"Hamadah A, Alwasaidi T, Le Gal G, Carrier M, Wells PS, Scarvelis D, Gonsalves C, Forgie M, Kovacs MJ, Rodger MA (2011) Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence. J Thromb Haemost 9:2406\u20132410. \nhttps:\/\/doi.org\/10.1111\/j.1538-7836.2011.04533.x","journal-title":"J Thromb Haemost"},{"key":"1944_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ejim.2008.02.006","volume":"19","author":"FA Klok","year":"2008","unstructured":"Klok FA, Tijmensen JE, Haeck MLA, van Kralingen KW, Huisman MV (2008) Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire. Eur J Intern Med 19:625\u2013629. \nhttps:\/\/doi.org\/10.1016\/j.ejim.2008.02.006","journal-title":"Eur J Intern Med"},{"key":"1944_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11239-010-0452-x","volume":"30","author":"D Poli","year":"2010","unstructured":"Poli D, Grifoni E, Antonucci E, Arcangeli C, Prisco D, Abbate R, Miniati M (2010) Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism. J Thromb Thrombolysis 30:294\u2013299. \nhttps:\/\/doi.org\/10.1007\/s11239-010-0452-x","journal-title":"J Thromb Thrombolysis"},{"key":"1944_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1160\/TH13-07-0538","volume":"112","author":"L Gu\u00e9rin","year":"2014","unstructured":"Gu\u00e9rin L, Couturaud F, Parent F, Revel M-P, Gillaizeau F, Planquette B, Pontal D, Gu\u00e9gan M, Simonneau G, Meyer G, Sanchez O (2014) Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 112:598\u2013605. \nhttps:\/\/doi.org\/10.1160\/TH13-07-0538","journal-title":"Thromb Haemost"},{"key":"1944_CR7","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa032274","volume":"350","author":"V Pengo","year":"2004","unstructured":"Pengo V, Lensing AWA, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P (2004) Thromboembolic pulmonary hypertension study group, incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257\u20132264. \nhttps:\/\/doi.org\/10.1056\/NEJMoa032274","journal-title":"N Engl J Med"},{"key":"1944_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1378\/chest.130.1.172","volume":"130","author":"C Becattini","year":"2006","unstructured":"Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 130:172\u2013175. \nhttps:\/\/doi.org\/10.1378\/chest.130.1.172","journal-title":"Chest"},{"key":"1944_CR9","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3324\/haematol.2009.018960","volume":"95","author":"FA Klok","year":"2010","unstructured":"Klok FA, van Kralingen KW, van Dijk APJ, Heyning FH, Vliegen HW, Huisman MV (2010) Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 95:970\u2013975. \nhttps:\/\/doi.org\/10.3324\/haematol.2009.018960","journal-title":"Haematologica"},{"key":"1944_CR10","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/j.thromres.2009.12.016","volume":"125","author":"S Surie","year":"2010","unstructured":"Surie S, Gibson NS, Gerdes VEA, Bouma BJ, van Eck BLF \u2013 Smit HR, Buller P, Bresser (2010) Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res 125:e202\u2013e205. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2009.12.016","journal-title":"Thromb Res"},{"key":"1944_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.thromres.2009.01.003","volume":"124","author":"F Dentali","year":"2009","unstructured":"Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, Ageno W (2009) Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 124:256\u2013258. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2009.01.003","journal-title":"Thromb Res"},{"key":"1944_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/686011","volume":"6","author":"DT Matthews","year":"2016","unstructured":"Matthews DT, Hemnes AR (2016) Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension. Pulm Circ 6:145\u2013154. \nhttps:\/\/doi.org\/10.1086\/686011","journal-title":"Pulm Circ"},{"key":"1944_CR13","doi-asserted-by":"publisher","unstructured":"Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, Dainelli A, Giuntini C (2006) Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 85:253\u2013262. \nhttps:\/\/doi.org\/10.1097\/01.md.0000236952.87590.c8","DOI":"10.1097\/01.md.0000236952.87590.c8"},{"key":"1944_CR14","doi-asserted-by":"publisher","first-page":"1601980","DOI":"10.1183\/13993003.01980-2016","volume":"49","author":"R Pesavento","year":"2017","unstructured":"Pesavento R, Filippi L, Palla A, Vison\u00e0 A, Bova C, Marzolo M, Porro F, Villalta S, Ciammaichella M, Bucherini E, Nante G, Battistelli S, Muiesan ML, Beltramello G, Prisco D, Casazza F, Ageno W, Palareti G, Quintavalla R, Monti S, Mumoli N, Zanatta N, Cappelli R, Cattaneo M, Moretti V, Cor\u00e0 F, Bazzan M, Ghirarduzzi A, Frigo AC, Miniati M, Prandoni P, SCOPE Investigators (2017) Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J 49:1601980. \nhttps:\/\/doi.org\/10.1183\/13993003.01980-2016","journal-title":"Eur Respir J"},{"key":"1944_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.thromres.2017.11.020","volume":"162","author":"T Wan","year":"2018","unstructured":"Wan T, Rodger M, Zeng W, Robin P, Righini M, Kovacs MJ, Tan M, Carrier M, Kahn SR, Wells PS, Anderson DR, Chagnon I, Solymoss S, Crowther M, White RH, Vickars L, Bazarjani S (2018) G. Le Gal, Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: results from the REVERSE cohort study. Thromb Res 162:104\u2013109. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2017.11.020","journal-title":"Thromb Res"},{"key":"1944_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1160\/TH12-07-0534","volume":"109","author":"D Poli","year":"2013","unstructured":"Poli D, Cenci C, Antonucci E, Grifoni E, Arcangeli C, Prisco D, Abbate R, Miniati M (2013) Risk of recurrence in patients with pulmonary embolism: Predictive role of d-dimer and of residual perfusion defects on lung scintigraphy. Thromb Haemost 109:181\u2013186. \nhttps:\/\/doi.org\/10.1160\/TH12-07-0534","journal-title":"Thromb Haemost"},{"key":"1944_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1160\/TH09-05-0301","volume":"102","author":"MP Donadini","year":"2009","unstructured":"Donadini MP, Dentali F, Cosmi B, Bozzato S, Neri C, Squizzato A, Venco A, Ageno W (2009) Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? Thromb Haemost 102:1287\u20131289. \nhttps:\/\/doi.org\/10.1160\/TH09-05-0301","journal-title":"Thromb Haemost"},{"key":"1944_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1160\/TH14-10-0842","volume":"114","author":"PL den Exter","year":"2015","unstructured":"den Exter PL, van Es J, Kroft LJM, Erkens PMG, Douma RA, Mos ICM, Jonkers G, Hovens MMC, Durian MF, ten Cate H, Beenen LFM, Kamphuisen PW, Huisman MV (2015) Prometheus follow-up investigators, thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism. Thromb Haemost 114:26\u201334. \nhttps:\/\/doi.org\/10.1160\/TH14-10-0842","journal-title":"Thromb Haemost"},{"key":"1944_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.thromres.2015.06.007","volume":"136","author":"AF Macedo","year":"2015","unstructured":"Macedo AF, Bell J, McCarron C, Conroy R, Richardson J, Scowcroft A, Sunderland T, Rotheram N (2015) Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink. Thromb Res 136:250\u2013260. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2015.06.007","journal-title":"Thromb Res"},{"key":"1944_CR20","doi-asserted-by":"publisher","first-page":"e42269","DOI":"10.1371\/journal.pone.0042269","volume":"7","author":"PMG Erkens","year":"2012","unstructured":"Erkens PMG, ten Cate H, B\u00fcller HR, Prins MH (2012) Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS One 7:e42269. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0042269","journal-title":"PLoS ONE"},{"key":"1944_CR21","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1111\/jth.14281","volume":"16","author":"RLR Carter","year":"2018","unstructured":"Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, C\u00f4t\u00e9 HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG (2018) Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity. J Thromb Haemost 16:2276\u20132288. \nhttps:\/\/doi.org\/10.1111\/jth.14281","journal-title":"J Thromb Haemost"},{"key":"1944_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2017.03.022","volume":"153","author":"P Prandoni","year":"2017","unstructured":"Prandoni P, Ageno W, Mumoli N, Zanatta N, Imberti D, Vison\u00e0 A, Ciammaichella M, Simioni L, Cappelli R, Bucherini E, Di Nisio M, Avruscio G, Camporese G, Parisi R, Cuppini S, Turatti G, Noventa F, Sarolo L (2017) Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res 153:97\u2013100. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2017.03.022","journal-title":"Thromb Res"},{"key":"1944_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1055\/s-0038-1676320","volume":"45","author":"M Lim","year":"2019","unstructured":"Lim M, Indran T, Cummins A, Bennett A, Wood E, Brown S, McQuilten Z, Tran H, Epi M, Chan N, Chunilal S (2019) Utility of a nurse-led pathway for patients with acute venous thromboembolism discharged on rivaroxaban: a prospective cohort study. Semin Thromb Hemost 45:187\u2013195. \nhttps:\/\/doi.org\/10.1055\/s-0038-1676320","journal-title":"Semin Thromb Hemost"},{"key":"1944_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jth.13336","volume":"14","author":"C Kearon","year":"2016","unstructured":"Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing G-J, Kyrle PA, Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease (2016) Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 14:1480\u20131483. \nhttps:\/\/doi.org\/10.1111\/jth.13336","journal-title":"J Thromb Haemost"},{"key":"1944_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"1944_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.thromres.2016.10.030","volume":"148","author":"B Planquette","year":"2016","unstructured":"Planquette B, Ferr\u00e9 A, Peron J, Vial-Dupuy A, Pastre J, Mourin G, Emmerich J, Collignon M-A, Meyer G, Sanchez O (2016) Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study. Thromb Res 148:70\u201375. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2016.10.030","journal-title":"Thromb Res"},{"key":"1944_CR27","first-page":"1043","volume":"41","author":"M Wartski","year":"2000","unstructured":"Wartski M, Collignon MA (2000) Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l\u2019Embolie Pulmonaire Study. J Nucl Med 41:1043\u20131048","journal-title":"J Nucl Med"},{"key":"1944_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF00253444","volume":"14","author":"K Hvid-Jacobsen","year":"1988","unstructured":"Hvid-Jacobsen K, Fogh J, Nielsen SL, Thomsen HS, Hartling OJ (1988) Scintigraphic control of pulmonary embolism. Eur J Nucl Med 14:71\u201372","journal-title":"Eur J Nucl Med"},{"key":"1944_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/rccm.201312-2251LE","volume":"189","author":"R Pesavento","year":"2014","unstructured":"Pesavento R, Filippi L, Pagnan A, Vison\u00e0 A, Pauletto P, Vescovo G, Cuppini S, Beltramello G, Villalta S, De Conti G, Vedovetto V, Frigo AC, Prandoni P, PROVE Investigators Group (2014) Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. Am J Respir Crit Care Med 189:1277\u20131279. \nhttps:\/\/doi.org\/10.1164\/rccm.201312-2251LE","journal-title":"Am J Respir Crit Care Med"},{"key":"1944_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejim.2011.08.018","volume":"23","author":"JL Alonso-Mart\u00ednez","year":"2012","unstructured":"Alonso-Mart\u00ednez JL, Anniccherico-S\u00e1nchez FJ, Urbieta-Echezarreta MA, Garc\u00eda-Sanchotena JL, Herrero HG (2012) Residual pulmonary thromboemboli after acute pulmonary embolism. Eur J Intern Med 23:379\u2013383. \nhttps:\/\/doi.org\/10.1016\/j.ejim.2011.08.018","journal-title":"Eur J Intern Med"},{"key":"1944_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11739-011-0577-8","volume":"6","author":"B Cosmi","year":"2011","unstructured":"Cosmi B, Nijkeuter M, Valentino M, Huisman MV, Barozzi L, Palareti G (2011) Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism. Intern Emerg Med 6:521\u2013528. \nhttps:\/\/doi.org\/10.1007\/s11739-011-0577-8","journal-title":"Intern Emerg Med"},{"key":"1944_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1538-7836.2010.03844.x","volume":"8","author":"O Sanchez","year":"2010","unstructured":"Sanchez O, Helley D, Couchon S, Roux A, Delaval A, Trinquart L, Collignon M-A, Fischer A-M, Meyer G (2010) Perfusion defects after pulmonary embolism: risk factors and clinical significance. J Thromb Haemost 8:1248\u20131255. \nhttps:\/\/doi.org\/10.1111\/j.1538-7836.2010.03844.x","journal-title":"J Thromb Haemost"},{"key":"1944_CR33","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1164\/ajrccm.154.5.8912753","volume":"154","author":"M Miniati","year":"1996","unstructured":"Miniati M, Pistolesi M, Marini C, Di Ricco G, Formichi B, Prediletto R, Allescia G, Tonelli L, Sostman HD, Giuntini C (1996) Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED). Am J Respir Crit Care Med 154:1387\u20131393. \nhttps:\/\/doi.org\/10.1164\/ajrccm.154.5.8912753","journal-title":"Am J Respir Crit Care Med"},{"key":"1944_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.thromres.2015.12.023","volume":"138","author":"F Semeraro","year":"2016","unstructured":"Semeraro F, Incampo F, Ammollo CT, Dellanoce C, Paoletti O, Testa S, Colucci M (2016) Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation. Thromb Res 138:22\u201329. \nhttps:\/\/doi.org\/10.1016\/j.thromres.2015.12.023","journal-title":"Thromb Res"},{"key":"1944_CR35","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1021\/bi002209v","volume":"40","author":"JE Grundy","year":"2001","unstructured":"Grundy JE, Lavigne N, Hirama T, MacKenzie CR, Pryzdial EL (2001) Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa. Biochemistry 40:6293\u20136302","journal-title":"Biochemistry"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01944-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01944-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01944-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:12:35Z","timestamp":1599261155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01944-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01944-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"assertion":[{"value":"6 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S Chunilal received grants from Bayer Pharma during the conduct of the study and advisory board fees from Bayer Pharma outside the submitted work; H Tran received grants and honorarium from Bayer Health, grants from Pfizer and honorarium from Boehringer-Ingelheim, all outside the submitted work. All other authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}